Augustine Daniel X, Keteepe-Arachi Tracey, Malhotra Aneil
Royal United Hospitals Bath NHS Foundation Trust Bath, UK.
Department for Health, University of Bath Bath, UK.
Eur Cardiol. 2021 Mar 2;16:e03. doi: 10.15420/ecr.2020.36. eCollection 2021 Feb.
Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2. While the majority of symptoms and morbidity relate to the lung, cardiac complications have been well reported and confer increased mortality. Many countries in Europe have passed the peak of the pandemic and adaptations are being made as we progress towards a 'new normal'. As part of this, governments have been planning strategies for the return of elite sports. This article summarises the potential implications of COVID-19 for athletes returning to sport, including common cardiac complications of the disease; consensus recommendations for the return to sport after having COVID-19; and international recommendations for the management of cardiac pathology that may occur as a result of COVID-19. The authors also examine the potential overlap of pathology with physiological change seen in athletes' hearts.
2019年冠状病毒病（COVID-19）由严重急性呼吸综合征冠状病毒2引起。虽然大多数症状和发病率与肺部有关，但心脏并发症已有充分报道，且会增加死亡率。欧洲许多国家已度过疫情高峰，随着我们迈向“新常态”，正在做出调整。在此过程中，各国政府一直在规划精英体育赛事恢复的策略。本文总结了COVID-19对恢复运动的运动员的潜在影响，包括该疾病常见的心脏并发症；感染COVID-19后恢复运动的共识性建议；以及针对可能因COVID-19而出现的心脏病变的国际管理建议。作者还研究了病变与运动员心脏中出现的生理变化之间的潜在重叠情况。
